Profil Financier
Dennis Gillings occupe actuellement le rang #1732 du classement mondial StarFortune (secteur santé & biotech). Fortune nette estimée : $2.4 B (-$200 sur 24h).
Dennis Gillings is the founder and former CEO and chairman of clinical research firm Quintiles Transnational, which changed its name to IQVIA in 2017.
Gillings, a former biostatistics professor, launched Quintiles in 1982 with the goal of making clinical trials for drugs faster and more efficient.
Gillings retired from the board of IQVIA in 2018.
Quintiles reached annual revenues of $5.7 billion before merging with healthcare data firm IMS Health in 2016.
Gillings received a Commander of the Order of the British Empire from Queen Elizabeth in 2004 for his work in the pharmaceutical industry.